Reliable identification of the physician–patient relationship is necessary for accurate evaluation. Standardization of evidence-based attribution methods is essential to improve the value of healthcare.
This observational study shows that clinical work performed by family physicians correlates poorly with common codes and fees under the existing coding and billing rules.
Community-based persons with Alzheimer’s disease have a higher risk of fractures, hospitalization, and various comorbidities than persons without the disease.
The authors present a brief summary of the types of payment arrangements that early accountable care organizations are adopting.
The authors established a claims-based mechanism for identifying patients with lung cancer with more severe patient-reported cancer-related symptoms who could benefit from engagement with health care programs.
This prospective trial suggests that specialized care coordination and health counseling for patients coping with advanced stages of 4 life-limiting illnesses can be beneficial.
Through a multi-site, multidisciplinary approach, AYA@USC addresses the unique needs of young adult cancer patients, improving outcomes and bridging the care gap in this population.
Private sector accountable care organization development has been motivated by perceived opportunities to improve quality, efficiency, and population health, and the belief that payment reform is inevitable.
Even small changes in average copayment for long-term controller asthma medications can result in significant reductions in medication use and increases in healthcare services.
Health systems are important in driving electronic health record adoption in ambulatory clinics, although the uptake of key functionalities varies across systems.
Vaccination of children born in the United States in 2009 will save 1.2 million quality-adjusted life-years, generating $184 billion in social value net of vaccination costs.
This article assesses a classification tool for categorizing emergency department visits as emergent and nonemergent.
The mean 24-week cost per participant was $5416 for extended-release injectable naltrexone (57% detoxification, 37% medication, 6% provider/patient) and $4148 for buprenorphine-naloxone (64% detoxification, 12% medication, 24% provider/patient).
Evaluation of cancer patients’ quality of life at admission enabled improvement of their satisfaction with received care at discharge.
This study demonstrates a major influence of prehypertension and hypertension on healthcare costs in a large cohort of children, independent of body mass index.
Clinical pathways have been emphasized as a means to deliver efficient, quality care and to ensure better outcomes at lower costs. The Oncology Medical Home takes this to the next, more comprehensive, step of quantifying and improving quality and value in cancer care while lowering overall costs.
Approximately 5% of non-elderly adults have a community acquired pneumonia (CAP) annually, with an annual total of $10.6 billion in direct and indirect costs.